A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies

Summary

To establish the safety and efficacy of HTL0018318 compared with placebo when administered once daily for 12 weeks to patients with dementia with Lewy bodies.

Timeline

Start

2019-07

Primary completion

2020-07

Completion

2021-01

Outcome

Outcome not reported

Stopped: “Pending investigation of an unexpected animal toxicology finding.”

Drugs

Indications